Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

23 Feb 2022 07:00

RNS Number : 4857C
Phoenix Group Holdings PLC
23 February 2022
 

LEI: 2138001P49OLAEU33T68

 

Board updates

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") announces the following Board changes.

 

As was previously noted in a press release dated 6 July 2021, Phoenix Group's Chairman, Nicholas Lyons, has been nominated for the prestigious role of Lord Mayor of the City of London beginning in November 2022 for a one-year term. The Board is delighted that its Chairman has been recognised in this way and has planned accordingly to enable him to take-up this full-time role. It is therefore planned that Mr Lyons will take a sabbatical from Phoenix Group commencing 1 September 2022 and will then return to his roles as Chairman of the Board of Directors and Chairman of the Nomination Committee in November 2023, subject to regulatory approval. To promote clarity of leadership during his sabbatical, Mr Lyons will formally resign from his roles on the Board for the period of his sabbatical.

 

As a result, the Board has agreed that, subject to regulatory approval, Alastair Barbour, currently the Group's Senior Independent Director, will assume the role of interim Chairman from 1 September 2022 for the term of Mr Lyons' sabbatical. The Board believes that not only is Mr Barbour the best appointee for this interim role, but also that his longstanding knowledge and commitment to Phoenix will ensure a consistent approach to Board matters.

 

The Board has also agreed that, subject to regulatory approval, Karen Green will succeed Alastair Barbour as Senior Independent Director beginning after the conclusion of Phoenix Group's 2022 Annual General Meeting on 5 May 2022. Ms Green is the Chair of the Board Sustainability Committee and the Designated Non-Executive Director for Workforce Engagement.

 

The Board is also pleased to announce the appointment of Katie Murray as an independent Non-Executive Director with effect from 1 April 2022. Katie is the Group Chief Financial Officer of the NatWest Group, a position she has held since January 2019, having joined NatWest as Director of Finance in November 2015. She is a director of NatWest Group plc. Katie has worked in Finance and Accounting for over 30 years. She was previously the Group Finance Director for Old Mutual Emerging Markets, based in Johannesburg from 2011 to 2015, having held various roles across Old Mutual since 2002. Prior to that, she worked at KPMG for 13 years. Katie is a Chartered Accountant, having trained in Scotland and is a member of the Institute of Chartered Accountants of Scotland.

 

Commenting on the changes, Nicholas Lyons, Phoenix Group Chairman, said:

 

"I am very grateful that the Board, our regulators and our major investors have been so supportive of my accepting the full-time, one year role of Lord Mayor of the City of London, commencing in November 2022, and I look forward to having the opportunity to help promote the UK's world-leading financial and professional services sectors and London as the pre-eminent global financial centre.".

 

The Board has planned thoughtfully for this situation and I am delighted that our Senior Independent Director, Alastair Barbour, is to be appointed as interim Chairman during my sabbatical. Alastair has been at Phoenix Group for over eight years now and has substantial chairing experience and technical skills, all of which make him the ideal candidate for this role. I am also delighted that Karen Green is to be appointed as our new Senior Independent Director to succeed Alastair. I know she will provide excellent support to both Alastair and me.

 

I am also very pleased that Katie Murray will be joining the Phoenix Group Board and we look forward to her bringing her wealth of experience to the Group. Katie brings deep finance and accounting skills built through her experience at a senior executive level across both the banking and insurance sectors, as well as her earlier private practice background."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASELFAEEESEEE
Date   Source Headline
3rd Jul 20233:30 pmRNSTotal Voting Rights
30th Jun 202311:30 amRNSPublication of a Prospectus
16th Jun 20233:01 pmRNSDirector Declaration
12th Jun 20231:30 pmRNSBlock Listing Return
7th Jun 20238:38 amRNSDirector/PDMR Shareholding
1st Jun 20231:24 pmRNSBlock Listing Application
1st Jun 20231:00 pmRNSTotal Voting Rights
16th May 202312:10 pmRNSDirector/PDMR Shareholding
11th May 20236:00 pmRNSDirectorate Change
10th May 20234:06 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSHolding(s) in Company
4th May 20232:19 pmRNSResult of AGM
2nd May 20233:00 pmRNSTotal Voting Rights
6th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSTotal Voting Rights
3rd Apr 20238:02 amRNSAcquisition
30th Mar 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20234:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:45 pmRNSNotice of AGM
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20235:00 pmRNSDirector/PDMR Shareholding
15th Mar 20235:30 pmRNSDirector/PDMR Shareholding
13th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNS2022 Annual Financial Report
10th Mar 20239:31 amRNSDirectorate Change - Replacement
10th Mar 20239:00 amRNSDirectorate Change
8th Mar 20234:00 pmRNSDirector/PDMR Shareholding
1st Mar 20232:00 pmRNSTotal Voting Rights
7th Feb 20233:45 pmRNSMiscellaneous - PGH/TCS Extension of Partnership
7th Feb 20232:30 pmRNSDirector/PDMR Shareholding
1st Feb 20232:00 pmRNSTotal Voting Rights
6th Jan 20234:30 pmRNSDirector/PDMR Shareholding
30th Dec 20221:00 pmRNSTotal Voting Rights
12th Dec 20224:30 pmRNSBlock listing Interim Review
7th Dec 20224:45 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSTrading Statement
30th Nov 20222:00 pmRNSTotal Voting Rights
8th Nov 20225:30 pmRNSDirector/PDMR Shareholding
31st Oct 20226:00 pmRNSTotal Voting Rights
12th Oct 20224:00 pmRNSDirectorate Change
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.